Venture Beat -
30 May 2017 20:25
PRESS RELEASE: Augmenix, Inc., a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy, today announced that it has received Shonin approval from...
Share this Article
Comment on this Article
Please to comment